Clinical Trial: Evaluation of BRC-002 Safety, Tolerability, Pharmacokinetics, and Food Effects in Healthy Participants

U.S., July 14 -- ClinicalTrials.gov registry received information related to the study (NCT07699120) titled 'Evaluation of BRC-002 Safety, Tolerability, Pharmacokinetics, and Food Effects in Healthy Participants' on July 02.

Brief Summary: This study will evaluate the safety and tolerability of BRC-002, an investigational botanical drug from cannabis, in healthy adults. The study will also assess how the body processes BRC-002 and whether taking it with food affects how it is absorbed or metabolized. The results of this study will help support further clinical development of BRC-002 and guide dose selection in patient populations.

Study Start Date: June 15

Study Type: INTERVENTIONAL

Condition: Healthy Adult Participants

Intervention: ...